A research-driven pharmaceutical and bioscience institution headquartered at GIFT City, India — structured for global regulated markets with WHO-GMP alignment, 10+ therapeutic platforms, and the Truvedika Ayurvedic wellness division.
Long-horizon governance with regulatory infrastructure designed for multi-decade healthcare value creation across global markets.
SCIBEX BIOSCIENCES Pvt. Ltd. is a research-driven pharmaceutical and bioscience company headquartered at GIFT City, Gandhinagar, Gujarat — India's first Smart City and International Financial Services Centre.
We operate at the convergence of pharmaceutical science, formulation innovation, and integrative bioscience, structured to serve global healthcare markets with precision, scientific rigour, and institutional integrity.
To advance accessible, evidence-based pharmaceutical solutions that improve long-term population health outcomes globally.
To be recognized as a trusted global bioscience institution known for scientific leadership, regulatory excellence, and long-term patient value.
Founded on the principle that world-class pharmaceutical research can be anchored in India and scaled globally.
| Legal Name | SCIBEX BIOSCIENCES Pvt. Ltd. |
| Incorporated | GIFT City, Gandhinagar, Gujarat, India |
| US Entity | SCIBEX BIOSCIENCES Inc. — New Jersey, USA |
| Chairman & MD | Harsh Shah |
| Chief Technology Officer | Purvesh Shah |
| Chief Financial Officer | Shubham Sharma |
| Co-Founder | Hemant Shah |
| Ayurvedic Division | Truvedika — www.truvedika.com ↗ |
| Therapeutic Focus | 10 Clinical Categories |
| Regulatory Framework | CDSCO • WHO-GMP • USFDA • EMA • ICH • CTD |
| Expansion Roadmap | India → USA → SE Asia → Europe/MENA |
| Website | www.scibexbiosciences.com ↗ |
End-to-end pharmaceutical value chain — from scientific concept to regulated global market
Proprietary formulation science for oral solid dosage forms, modified-release systems, and targeted drug delivery architectures.
Rigorous quality control through HPLC, dissolution testing, stability protocols, and validated analytical methods ensuring full regulatory compliance.
Interdisciplinary science combining molecular biology, PK/PD modeling, and clinical data to build evidence-supported therapeutic portfolios.
Dedicated regulatory affairs aligned with CDSCO, USFDA, EMA, and WHO-GMP. Complete CTD/eCTD dossier preparation and pharmacovigilance.
Nutraceutical science, immunomodulatory compounds, and evidence-based preventive formulations targeting chronic lifestyle and metabolic disorders.
Structured PLM from IND through NDA to post-marketing surveillance, ensuring regulatory compliance and commercial maximization at every stage.
Spanning chronic disease, lifestyle disorders, and evidence-based preventive healthcare — targeting the world's most significant unmet clinical needs
Full compliance with international pharmaceutical regulations — audit-ready at every stage of development and manufacturing.
Facilities designed in strict alignment with WHO-GMP and Schedule M frameworks. Full audit readiness for national and international inspections.
Comprehensive post-market safety surveillance including adverse event monitoring, signal detection, ICSR reporting per ICH E2 guidelines.
Complete CTD/eCTD documentation for CDSCO, USFDA, and EMA submissions with structured technical writing and archival systems.
ICH Q1A/Q1B accelerated and real-time stability studies, validated HPLC methodologies ensuring pharmaceutical quality across shelf life.
Formal deviation management, root-cause investigation, CAPA workflows, and version-controlled SOP documentation maintaining continuous quality integrity.
Systematic qualification of API, excipient, and packaging material suppliers through vendor audits, CoA review, and approved supplier listing.
Dual-territory operations platform connecting India's pharmaceutical excellence to world markets.
SCIBEX BIOSCIENCES Pvt. Ltd., GIFT City (Gujarat International Finance Tec-City), Gandhinagar, Gujarat 382 355. India's premier institutional hub providing regulatory proximity, world-class infrastructure, and direct access to pharmaceutical sector leadership and capital markets.
SCIBEX BIOSCIENCES Inc., New Jersey — US East Coast Pharmaceutical Corridor. Strategic gateway into the world's largest pharmaceutical market. Positioned to support Medical Affairs, USFDA regulatory submissions, licensing and partnership development.
| Therapeutic Area | Priority | Status | Target Markets | Timeline |
|---|---|---|---|---|
| Cardiovascular | Very High | Active Development | India, USA, GCC | 18–24 Months |
| Diabetes & Metabolic | Very High | Active Development | India, USA, SE Asia | 18–24 Months |
| Gastrointestinal | High | Formulation Stage | India, GCC | 24–30 Months |
| Respiratory | High | Pre-Formulation | India, USA | 24–36 Months |
| Women's Health | High | Active Development | India, MENA | 18–24 Months |
| Mental Wellness | Growing | Pipeline | USA, India | 30–42 Months |
India-based pharmaceutical companies uniquely positioned to capture global generics, specialty, and integrative wellness market growth.
A division of SCIBEX BIOSCIENCES Pvt. Ltd. — derived from Sanskrit, representing Truth (Satya), Knowledge (Vidya), and Holistic Healing. Every product is grounded in classical Ayurvedic texts — Charaka Samhita, Sushruta Samhita, Ashtanga Hridayam — validated through modern analytical methodology and GMP manufacturing standards.
Visit Truvedika Website →Rooted in classical Ayurvedic texts validated through modern analytical and clinical methodologies. Every ingredient authenticity verified and quality tested.
Manufactured under GMP-compliant conditions using sustainably sourced, authentically identified botanical raw materials with full batch traceability.
Ayurveda's tridosha principle — addressing the root cause of imbalance. Whole-person wellness for modern, high-performance lifestyles.
Responsibly sourced herbs with full supply chain traceability, protecting India's biodiversity and supporting local farming communities.
"Where Ayurvedic Wisdom Meets Modern Science"
Explore the complete Truvedika range
Visit www.truvedika.com ↗Experienced executives across pharmaceutical science, technology, finance, and Ayurvedic medicine.
Founder and institutional leader. Brings deep expertise in pharmaceutical sciences, strategic governance, and long-term business development across India and global healthcare markets. Architect of SCIBEX's institutional vision.
Leads technology infrastructure, digital transformation, and scientific systems. Responsible for all R&D technology platforms, enterprise architecture, and innovation strategy across pharmaceutical and digital domains.
Oversees financial strategy, investor relations, corporate finance, and capital allocation across pharmaceutical and Ayurvedic divisions. Leads institutional fundraising, M&A evaluation, and financial governance frameworks.
Co-founder of SCIBEX and Managing Director of Truvedika. Deep expertise in Ayurvedic science, traditional medicine systems, and wellness brand development. Leads all Truvedika product and commercial strategy.
Co-founder and Director of Truvedika with deep passion for authentic Ayurvedic wellness and traditional knowledge systems. Oversees product quality philosophy and brand authenticity across all Truvedika formulations.
Responsible for all clinical formulation decisions, classical text-based product development, and therapeutic protocol design. Ensures authenticity, safety, and clinical relevance of all Truvedika formulations.
Structured for institutional transparency, long-term value creation, and sustainable growth. Built not for the quarter — but for the decade.
Independent oversight framework with audit, compliance, and scientific advisory committees ensuring accountability across all SCIBEX group entities.
Disciplined organic R&D expansion, strategic licensing, branded partnerships, and phased market entry — India → USA → Global corridors.
Full disclosure framework for GMP, PV reporting, and regulatory status. Audit-ready documentation accessible to qualified institutional investors.
Formulation patents, proprietary process development, and technology licensing as core IP value creation and competitive moat for SCIBEX.
Compounding value through diversified therapeutic portfolio, regulated market access, and science-led differentiation over a multi-decade institution-building horizon.
Responsible manufacturing, equitable access to medicines, biodiversity protection through Truvedika, and transparent governance across all group operations.
"We exist to advance the health of people everywhere — through rigorous pharmaceutical science and the timeless wisdom of Ayurveda — one product, one patient, one generation at a time."
SCIBEX BIOSCIENCES Pvt. Ltd.
GIFT City (Gujarat International Finance Tec-City)
Gandhinagar, Gujarat 382 355, India
+91 9974062755
business@scibexbiosciences.com
www.scibexbiosciences.com
SCIBEX BIOSCIENCES Inc.
New Jersey, United States of America
(US East Coast Pharmaceutical Corridor)
+1 551 256 0660
Medical Affairs · Regulatory Filings · Partnership Development
Under SCIBEX BIOSCIENCES Pvt. Ltd.
Products: FEBRIVA · TRUPRA · HEPRA · RESPIRA DNA
www.truvedika.com ↗